Tests

1st tests to order

direct immunofluorescence microscopy

Test
Result
Test

Perform a skin biopsy of perilesional skin for direct immunofluorescence microscopy in all patients with suspected dermatitis herpetiformis.[2][20][21] This is the definitive investigation for diagnosing the condition.[2][11][16][20]

The optimal biopsy site is perilesional, uninvolved skin because direct immunofluorescence microscopy performed on lesional biopsies rather than perilesional skin often leads to false-negative results.[2][22] If a patient with high suspicion of dermatitis herpetiformis tests negative at direct immunofluorescence microscopy, request a repeat skin biopsy; false-negative results after repeated biopsies are very rare.[23]

Result

granular IgA deposits at the dermal papillae or along the dermal-epidermal junction

histopathologic exam

Test
Result
Test

Perform a skin biopsy of lesional skin for histopathologic exam in all patients with suspected dermatitis herpetiformis.[2][21] Take a 4-5 mm lesional punch biopsy.[2] This test is not specific, but can help to identify differential diagnoses.

Result

accumulation of neutrophils in the dermal papillae and subepidermal blister

immunoglobulin A-tissue transglutaminase (IgA-tTG)

Test
Result
Test

Order in all patients with suspected dermatitis herpetiformis.[2]

IgA-tTG can give information on the presence of bowel damage (a normal result does not exclude dermatitis herpetiformis). IgA-tTG detected by enzyme-linked immunosorbent assay (ELISA) is present in up to 95% of patients.[25]

Result

titer above normal range for laboratory

endomysial antibody (EMA)

Test
Result
Test

Order in patients with suspected dermatitis herpetiformis if immunoglobulin A-tissue transglutaminase (IgA-tTG) testing is negative.[2] EMA has a greater specificity but lower sensitivity than IgA-tTG.[26][27][28]

Result

elevated titer

Tests to consider

human leukocyte antigen (HLA) typing

Test
Result
Test

Order in patients with suspected dermatitis herpetiformis in case of diagnostic uncertainty in order to exclude the disease. The test has a high negative predictive value.[2] Virtually all patients with dermatitis herpetiformis have a positive HLA-DQ2 (around 95%) or HLA-DQ8 (around 5%).[10]

Result

positive HLA-DQ2 or HLA-DQ8

CBC

Test
Result
Test

Perform a CBC with differential, with or without ferritin levels, to assess for anemia in patients with confirmed dermatitis herpetiformis and to obtain baseline levels prior to commencement of treatment.[2]

Result

variable - low Hb and microcytic hypochromic red cells may be present in patients with bowel involvement

gastroscopy with duodenal biopsy

Test
Result
Test

Consider referral of patients with confirmed dermatitis herpetiformis to a gastroenterologist, who may order gastroscopy with duodenal biopsy to assess bowel involvement.[2]

Result

villous atrophy in the duodenal and/or jejunal mucosa

Use of this content is subject to our disclaimer